Relationship between the expression of ompF and quinolone resistance in Escherichia coli

Journal of Infection and Chemotherapy

Volumn 15, Issue 6, 2009, Pages 361-366

  Kishii, Ryuta ^a   Takei, Masaya ^a  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Fitness cost; GyrA; OmpF; Quinolone

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NORFLOXACIN; OUTER MEMBRANE PROTEIN F; PROTEIN PARC; PROTEIN PARE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; URINARY TRACT INFECTION;

EID: 76749160324     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0716-6     Document Type: Article

References (25)

1. L.A. Egger H. Park M. Inouye 1997 Signal transduction via the histidylaspartyl phosphorelay Genes Cells 2 167 184 10.1046/j.1365-2443.1997. d01-311.x 1:CAS:528:DyaK2sXjsF2gsL4%3D 9189755
2. T. Mizuno M.Y. Chou M. Inouye 1984 A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA) Proc Natl Acad Sci U S A 81 1966 1970 10.1073/pnas.81.7.1966 1:CAS:528:DyaL2cXktFygsL8%3D 6201848
3. S. Chen A. Zhang L.B. Blyn G. Storz 2004 MicC, a second small-RNA regulator of Omp protein expression in Escherichia coli J Bacteriol 186 6689 6697 10.1128/JB.186.20.6689-6697.2004 1:CAS:528:DC%2BD2cXptVKrs7Y%3D 15466019 (Pubitemid 39332105)
4. S.P. Cohen L.M. McMurry D.C. Hooper J.S. Wolfson S.B. Levy 1989 Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction Antimicrob Agents Chemother 33 1318 1325 1:CAS:528:DyaL1MXltlSmtL8%3D 2679373
5. K. Miller A.J. O'Neill I. Chopra 2004 Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections Antimicrob Agents Chemother 48 23 29 10.1128/AAC.48.1.23-29.2004 1:CAS:528:DC%2BD2cXlsVKluw%3D%3D 14693514 (Pubitemid 38040172)
6. M.M. Tavio J. Vila J. Ruiz A.M. Martin-Sanchez M.T. Jimenez de Anta 1999 Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates J Antimicrob Chemother 44 735 742 10.1093/jac/44.6.735 1:STN:280:DC%2BD3c%2FlvFOktg%3D%3D 10590273
7. P. Neves E. Berkane P. Gameiro M. Winterhalter B. de Castro 2005 Interaction between quinolone antibiotics and bacterial outer membrane porin OmpF Biophys Chem 113 123 128 10.1016/j.bpc.2004.08.004 1:CAS:528: DC%2BD2cXhtFGhtL7P 15617818 (Pubitemid 40029726)
8. H.Y. Chenia B. Pillay D. Pillay 2006 Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens J Antimicrob Chemother 58 1274 1278 10.1093/jac/dkl404 1:CAS:528:DC%2BD28Xht1Ogsr7J 17040923 (Pubitemid 44884152)
9. H. Yoshida M. Bogaki M. Nakamura S. Nakamura 1990 Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli Antimicrob Agents Chemother 34 1271 1272 1:CAS:528:DyaK3cXkvFaitLs%3D 2168148
10. L. Ferrero B. Cameron B. Manse, et al. 1994 Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones Mol Microbiol 13 641 653 10.1111/j.1365-2958.1994.tb00458.x 1:CAS:528:DyaK2cXmvFCisrw%3D 7997176 (Pubitemid 24266200)
11. H.J. Leying K.H. Buscher W. Cullmann R.L. Then 1992 Lipopolysaccharide alterations responsible for combined quinolone and betalactam resistance in Pseudomonas aeruginosa Chemotherapy 38 82 91 10.1159/000238946 1:CAS:528:DyaK38XitlWktrw%3D 1591950
12. D.C. Hooper J.S. Wolfson K.S. Souza C. Tung G.L. McHugh M.N. Swartz 1986 Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli Antimicrob Agents Chemother 29 639 644 1:CAS:528: DyaL28XhvVeitL0%3D 3010850
13. J.H. Tran G.A. Jacoby 2002 Mechanism of plasmid-mediated quinolone resistance Proc Natl Acad Sci U S A 99 5638 5642 10.1073/pnas.082092899 1:CAS:528:DC%2BD38XjtFKltLY%3D 11943863 (Pubitemid 34411602)
14. A. Robicsek J. Strahilevitz G.A. Jacoby, et al. 2006 Fluoroquinolone- modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Nat Med 12 83 88 10.1038/nm1347 1:CAS:528:DC%2BD28Xht1Kmtg%3D%3D 16369542 (Pubitemid 43050081)
15. B. Perichon P. Courvalin M. Galimand 2007 Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli Antimicrob Agents Chemother 51 2464 2469 10.1128/AAC.00143-07 1:CAS:528:DC%2BD2sXnsVWqu7k%3D 17470656 (Pubitemid 47047325)
16. K. Hirai H. Aoyama S. Suzue T. Irikura S. Iyobe S. Mitsuhashi 1986 Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12 Antimicrob Agents Chemother 30 248 253 1:CAS:528:DyaL28XltFWrsLs%3D 3532944
17. S.P. Cohen L.M. McMurry S.B. Levy 1988 marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli J Bacteriol 170 5416 422 1:CAS:528:DyaL1MXntVWgsw%3D%3D 2848006
18. K. Hirai H. Aoyama M. Hosaka, et al. 1986 In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative Antimicrob Agents Chemother 29 1059 1066 1:CAS:528:DyaL28Xkslaisbs%3D 2942103
19. D. Ince D.C. Hooper 2003 Quinolone resistance due to reduced target enzyme expression J Bacteriol 185 6883 6892 10.1128/JB.185.23.6883-6892.2003 1:CAS:528:DC%2BD3sXpt1ynu7c%3D 14617652 (Pubitemid 37444490)
20. E. Kugelberg S. Lofmark B. Wretlind D.I. Andersson 2005 Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa J Antimicrob Chemother 55 22 30 10.1093/jac/dkh505 1:CAS:528:DC%2BD2MXkt1ajsw%3D%3D 15574475 (Pubitemid 40192610)
21. S.H. Gillespie L.L. Voelker A. Dickens 2002 Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae Microb Drug Resist 8 79 84 10.1089/107662902760190617 1:CAS:528:DC%2BD38XlvVKgurs%3D 12118521
22. E. Giraud A. Cloeckaert S. Baucheron C. Mouline E. Chaslus-Dancla 2003 Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium J Med Microbiol 52 697 703 10.1099/jmm.0.05178-0 12867565 (Pubitemid 36981479)
23. P. Komp Lindgren L.L. Marcusson D. Sandvang N. Frimodt-Moller D. Hughes 2005 Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections Antimicrob Agents Chemother 49 2343 2351 10.1128/AAC.49.6.2343-2351.2005 15917531 (Pubitemid 40734464)
24. D.E. Rozen L. McGee B.R. Levin K.P. Klugman 2007 Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob Agents Chemother 51 412 416 10.1128/AAC.01161-06 1:CAS:528:DC%2BD2sXhsVOqtbs%3D 17116668 (Pubitemid 46185254)
25. L.P. Randall M.J. Woodward 2002 The multiple antibiotic resistance (mar) locus and its significance Res Vet Sci 72 87 93 10.1053/rvsc.2001.0537 1:CAS:528:DC%2BD38XlsVKlu7c%3D 12027588 (Pubitemid 34679286)